Abstract:Therapeutic monoclonal antibodies (mAbs) have a propensity to host a large number of chemical and enzymatical modifications that need to be properly assessed for their potential impact on target binding. Traditional strategies of assessing the criticality of these attributes often involve a laborious and low-throughput variant enrichment step prior to binding affinity measurement. Here, we developed a novel competitive binding-based enrichment strategy followed by mass spectrometry analysis (namely, competitive binding-MS) to achieve high-throughput evaluation of potential critical quality attributes in therapeutic mAbs. Leveraging the differences in target binding capability under competitive binding conditions, the criticality of multiple mAb attributes can be simultaneously evaluated by quantitative mass spectrometry analysis. The utility of this new workflow was demonstrated in three mAb case studies, where different post-translational modifications occurring within the complementarity-determining regions were successfully interrogated for their impact on antigen binding. As this workflow does not require prior enrichment (e.g., by forced degradation or liquid chromatography fractionation) of the variants, it is particularly valuable during the mAb candidate developability assessment, where fast turn-around time is highly desired to assist candidate selection.Abbreviations: ACN: acetonitrile; ADCC: antibody-dependent cell-mediated cytotoxicity; AEX: anion exchange chromatography; bsAb: bispecific antibody; CDC: complement-dependent cytotoxicity; CDR: complementarity-determining region; CML: carboxymethylation; CQA: critical quality attribute; DDA: data-dependent acquisition; DMSO: dimethyl sulfoxide; DTT: dithiothreitol; FA: formic acid; Fab: Fragment antigen-binding; FcRn: neonatal Fc receptor; HC: heavy chain; HIC: hydrophobic interaction chromatography; IAA: iodoacetamide; IEX: ion exchange chromatography; LC: light chain; mAb monoclonal antibody; msAb: monospecific antibody; MS: mass spectrometry; PBS: phosphate-buffered saline; pI: isoelectric point; PTM: post-translational modification; SCX: strong cation exchange chromatography; SEC: size exclusion chromatography; SPR: surface plasmon resonance; XIC: extracted ion chromatography.

AbSE Workflow: Rapid Identification of the Coding Sequence and Linear Epitope of the Monoclonal Antibody at the Single-cell Level

Epitope binning for multiple antibodies simultaneously using mammalian cell display and DNA sequencing

Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run

Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryoEM

PAbFold: Linear Antibody Epitope Prediction using AlphaFold2

Antibody binding epitope Mapping (AbMap) of two hundred antibodies in a single run

Fast protein sequencing of monoclonal antibody by real-time digestion on emitter during nanoelectrospray

A Microfluidic Chip For Screening And Sequencing Of Monoclonal Antibody At A Single-Cell Level

Deciphering single-cell protein secretion and gene expressions by constructing cell-antibody conjugates

Genome-wide epitope identification with single-amino-acid resolution via high-throughput and unbiased peptide analysis

EpiScan: accurate high-throughput mapping of antibody-specific epitopes using sequence information

Single-domain antibody screening by is PLA-seq

SEPPA-mAb: Spatial Epitope Prediction of Protein Antigens for Mabs.

Integrating De Novo Sequencing and Database Search for Monoclonal Antibody Sequencing

Do-it-yourself de novo antibody sequencing workflow that achieves complete accuracy of the variable regions

Comprehensive assembly of monoclonal and mixed antibody sequences

Using a Machine-Learning Approach to Predict Discontinuous Antibody-Specific B-Cell Epitopes

Simultaneous polyclonal antibody sequencing and epitope mapping by cryo electron microscopy and mass spectrometry - a perspective.

Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation

A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies

Rapid and cost-effective epitope mapping using PURE ribosome display coupled with next-generation sequencing and bioinformatics